|
|
||||||||




* Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy;
Department of Oncology, London Regional Cancer Center, London, Ontario, Canada;
Department of Physiology; University of Siena, Siena, Italy; and
Department of Human Anatomy and Histology, University of Bari, Bari, Italy
The cytokine/extracellular matrix protein osteopontin (OPN/Eta-1) is an important component of cellular immunity and inflammation. It also acts as a survival, cell-adhesive, and chemotactic factor for endothelial cells. Here, subtractive suppression hybridization showed that serum-deprived murine aortic endothelial (MAE) cells transfected with the angiogenic fibroblast growth factor-2 (FGF2) overexpress OPN compared with parental cells. This was confirmed by Northern blotting and Western blot analysis of the conditioned media in different clones of endothelial cells overexpressing FGF2 and in endothelial cells treated with the recombinant growth factor. In vivo, FGF2 caused OPN expression in newly formed endothelium of the chick embryo chorioallantoic membrane (CAM) and of murine s.c. Matrigel plug implants. Recombinant OPN (rOPN), the fusion protein GST-OPN, and the deletion mutant GST-
RGD-OPN were angiogenic in the CAM assay. Angiogenesis was also triggered by OPN-transfected MAE cells grafted onto the CAM. OPN-driven neovascularization was independent from endothelial
v
3 integrin engagement and was always paralleled by the appearance of a massive mononuclear cell infiltrate. Accordingly, rOPN, GST-OPN, GST-
RGD-OPN, and the conditioned medium of OPN-overexpressing MAE cells were chemotactic for isolated human monocytes. Also, rOPN triggered a proangiogenic phenotype in human monocytes by inducing the expression of the angiogenic cytokines TNF-
and IL-8. OPN-mediated recruitment of proangiogenic monocytes may represent a mechanism of amplification of FGF2-induced neovascularization during inflammation, wound healing, and tumor growth.
This article has been cited by other articles:
![]() |
M. Kohan, R. Breuer, and N. Berkman Osteopontin Induces Airway Remodeling and Lung Fibroblast Activation in a Murine Model of Asthma Am. J. Respir. Cell Mol. Biol., September 1, 2009; 41(3): 290 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. BOSCO, S. DELFINO, F. FERLITO, M. PUPPO, A. GREGORIO, C. GAMBINI, M. GATTORNO, A. MARTINI, and L. VARESIO The Hypoxic Synovial Environment Regulates Expression of Vascular Endothelial Growth Factor and Osteopontin in Juvenile Idiopathic Arthritis J Rheumatol, June 1, 2009; 36(6): 1318 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Anderberg, H. Li, L. Fredriksson, J. Andrae, C. Betsholtz, X. Li, U. Eriksson, and K. Pietras Paracrine Signaling by Platelet-Derived Growth Factor-CC Promotes Tumor Growth by Recruitment of Cancer-Associated Fibroblasts Cancer Res., January 1, 2009; 69(1): 369 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Dunlap, D. W. Erikson, R. C. Burghardt, F. J. White, K. M. Reed, J. L. Farmer, T. E. Spencer, R. R. Magness, F. W. Bazer, K. J. Bayless, et al. Progesterone and Placentation Increase Secreted Phosphoprotein One (SPP1 or Osteopontin) in Uterine Glands and Stroma for Histotrophic and Hematotrophic Support of Ovine Pregnancy Biol Reprod, November 1, 2008; 79(5): 983 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Duvall, D. Weiss, S. T. Robinson, F. M.F. Alameddine, R. E. Guldberg, and W. R. Taylor The Role of Osteopontin in Recovery from Hind Limb Ischemia Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 290 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leali, E. Moroni, F. Bussolino, and M. Presta Osteopontin Overexpression Inhibits in Vitro Re-endothelialization via Integrin Engagement J. Biol. Chem., July 6, 2007; 282(27): 19676 - 19684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Herington and B. M Bany The conceptus increases secreted phosphoprotein 1 gene expression in the mouse uterus during the progression of decidualization mainly due to its effects on uterine natural killer cells Reproduction, June 1, 2007; 133(6): 1213 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kolanczyk, N. Kossler, J. Kuhnisch, L. Lavitas, S. Stricker, U. Wilkening, I. Manjubala, P. Fratzl, R. Sporle, B. G. Herrmann, et al. Multiple roles for neurofibromin in skeletal development and growth Hum. Mol. Genet., April 15, 2007; 16(8): 874 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Naldini, D. Leali, A. Pucci, E. Morena, F. Carraro, B. Nico, D. Ribatti, and M. Presta Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes J. Immunol., October 1, 2006; 177(7): 4267 - 4270. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sodek, A. P. Batista Da Silva, and R. Zohar Osteopontin and Mucosal Protection Journal of Dental Research, May 1, 2006; 85(5): 404 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mitola, M. Belleri, C. Urbinati, D. Coltrini, B. Sparatore, M. Pedrazzi, E. Melloni, and M. Presta Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine J. Immunol., January 1, 2006; 176(1): 12 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Riboldi, T. Musso, E. Moroni, C. Urbinati, S. Bernasconi, M. Rusnati, L. Adorini, M. Presta, and S. Sozzani Cutting Edge: Proangiogenic Properties of Alternatively Activated Dendritic Cells J. Immunol., September 1, 2005; 175(5): 2788 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gattorno, A. Gregorio, F. Ferlito, V. Gerloni, A. Parafioriti, E. Felici, E. Sala, C. Gambini, P. Picco, and A. Martini Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis Rheumatology, September 1, 2004; 43(9): 1091 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Fukushi, I. T. Makagiansar, and W. B. Stallcup NG2 Proteoglycan Promotes Endothelial Cell Motility and Angiogenesis via Engagement of Galectin-3 and {alpha}3{beta}1 Integrin Mol. Biol. Cell, August 1, 2004; 15(8): 3580 - 3590. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |